Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aul

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
European Journal of Haematology|April 25, 2000
Acute promyelocytic leukemia and pregnancyA A Giagounidis, M W Beckmann, A S Giagounidis, et al.
Annals of Hematology|May 1, 1997
S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
Leukemia|February 1, 1995
Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemiaG Meckenstock, A Heyll, E M Schneider, et al.
British Journal of Haematology|August 16, 2005
High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised studyR Fenk, P Schneider, M Kropff, et al.
Leukemia|October 1, 1992
Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cellsL W Terstappen, M Safford, M Unterhalt, et al.
Annals of Hematology|June 1, 1994
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemiaA Heyll, C Aul, F Gogolin, et al.
Leukemia & Lymphoma|January 1, 1993
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia Research|December 8, 2017
Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMMLE Schuler, F Frank, B Hildebrandt, et al.
Seminars in Hematology|July 1, 1991
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia|January 1, 1992
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCGT Büchner, W Hiddemann, B Wörmann, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
European Journal of Haematology|April 25, 2000
Acute promyelocytic leukemia and pregnancyA A Giagounidis, M W Beckmann, A S Giagounidis, et al.
Annals of Hematology|May 1, 1997
S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.
Leukemia|February 1, 1995
Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemiaG Meckenstock, A Heyll, E M Schneider, et al.
British Journal of Haematology|August 16, 2005
High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised studyR Fenk, P Schneider, M Kropff, et al.
Leukemia|October 1, 1992
Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cellsL W Terstappen, M Safford, M Unterhalt, et al.
Annals of Hematology|June 1, 1994
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemiaA Heyll, C Aul, F Gogolin, et al.
Leukemia & Lymphoma|January 1, 1993
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia Research|December 8, 2017
Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMMLE Schuler, F Frank, B Hildebrandt, et al.
Seminars in Hematology|July 1, 1991
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia|January 1, 1992
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCGT Büchner, W Hiddemann, B Wörmann, et al.
Pageof 18